objectives determine early identification babies cystic fibrosis cf improves outcome current environment new improved treatments considering criticism marginal benefit gained cf newborn screening nbs study design tested cf nbs setting modern cf center care afforded benefit using uk cf database ukcfd compare clinical outcomes infants underwent nbs control subjects clinically diagnosed cd rank tests NUMBER patients underwent nbs aged NUMBER NUMBER years NUMBER excluding meconium ileus compared matched patients cd age groups NUMBER control subjects results patients old NUMBER years underwent nbs significantly greater median height severe northern chest radiography scores better scores lower rates chronic pseudomonas aeruginosa infection difference weight predicted forced expiratory value NUMBER second forced volume capacity nutritional benefit demonstrated patients underwent nbs homozygous deltaf508 mutation conclusions nbs segregates better outcomes patients old NUMBER years compared control subjects cd study shows infants undergo screening derive nutritional benefit improved median height reduced morbidity mann whitney NUMBER year z scores shwachman kulczycki z score age gene matched cross sectional